About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cancer Immunology Research
›
top-articles
Cancer Immunology Research
6.8
(top 5%)
impact factor
1.5K
(top 20%)
papers
76.2K
(top 5%)
citations
130
(top 5%)
h
-index
6.9
(top 5%)
impact factor
2.0K
all documents
84.8K
doc citations
208
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Myeloid-Derived Suppressor Cells
Cancer Immunology Research
2017
1,345
2
PD-L1 Expression in Triple-Negative Breast Cancer
Cancer Immunology Research
2014
994
3
NF-κB, an Active Player in Human Cancers
Cancer Immunology Research
2014
913
4
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Cancer Immunology Research
2013
726
5
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Cancer Immunology Research
2014
711
6
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Cancer Immunology Research
2019
691
7
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Cancer Immunology Research
2015
631
8
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer
Cancer Immunology Research
2013
599
9
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
Cancer Immunology Research
2015
520
10
In Vitro
Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and
In Vivo
Toxicology in Non-Human Primates
Cancer Immunology Research
2014
514
11
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
Cancer Immunology Research
2014
512
12
NKG2D Receptor and Its Ligands in Host Defense
Cancer Immunology Research
2015
508
13
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
Cancer Immunology Research
2013
489
14
Tumors: Wounds That Do Not Heal—Redux
Cancer Immunology Research
2015
465
15
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Cancer Immunology Research
2016
456
16
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
Cancer Immunology Research
2014
448
17
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Cancer Immunology Research
2016
428
18
Chemokines in Cancer
Cancer Immunology Research
2014
417
19
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Cancer Immunology Research
2014
408
20
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for
In Vivo
Antitumor Activity
Cancer Immunology Research
2015
406
21
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Cancer Immunology Research
2017
400
22
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Cancer Immunology Research
2015
391
23
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
Cancer Immunology Research
2015
387
24
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Cancer Immunology Research
2015
387
25
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Cancer Immunology Research
2015
381
26
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Cancer Immunology Research
2017
381
27
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
Cancer Immunology Research
2017
354
28
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
Cancer Immunology Research
2015
342
29
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Cancer Immunology Research
2016
339
30
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Cancer Immunology Research
2013
333
31
The Immunological Synapse
Cancer Immunology Research
2014
330
32
PD-1 Restrains Radiotherapy-Induced Abscopal Effect
Cancer Immunology Research
2015
327
33
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Cancer Immunology Research
2014
322
34
PD-1 Blockade Expands Intratumoral Memory T Cells
Cancer Immunology Research
2016
321
35
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Cancer Immunology Research
2017
321
36
Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody
Cancer Immunology Research
2015
314
37
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
Cancer Immunology Research
2015
310
38
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
Cancer Immunology Research
2017
309
39
Oncolytic Viruses and Their Application to Cancer Immunotherapy
Cancer Immunology Research
2014
308
40
T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Cancer Immunology Research
2018
297
41
Molecular Drivers of the Non–T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
Cancer Immunology Research
2016
293
42
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Cancer Immunology Research
2015
292
43
The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis
Cancer Immunology Research
2016
290
44
Inflammasomes and Cancer
Cancer Immunology Research
2017
290
45
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
Cancer Immunology Research
2015
285
46
Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity
In Vivo
Cancer Immunology Research
2013
284
47
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Cancer Immunology Research
2017
284
48
The Biology and Medical Implications of Interleukin-6
Cancer Immunology Research
2014
283
49
Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
Cancer Immunology Research
2014
278
50
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
Cancer Immunology Research
2014
276
site/software ©
exaly
; All materials licenced under
CC by-SA
.